Peritoneum is a site for both primary and secondary tumors. Primary peritoneal tumors are fairly rare. The most common primary tumors of the peritoneum are malignant mesothelioma and serous papillary adenocarcinoma. Clear cell carcinoma of the peritoneum is extremely rare and often misdiagnosed as mesothelioma, serous carcinoma, or metastatic adenocarcinoma, so it represents a diagnostic challenge for both clinicians and pathologists. Up to date, to the best of our knowledge, only 11 cases of primary peritoneal clear cell carcinoma have been reported in the English literature. Distinguishing this tumor of the peritoneum versus ovarian carcinoma can be problematic. Herein, we report a rare case of primary peritoneal clear cell carcinoma occurring in a 49-year-old woman, along with a review of the literature.
ScullyREYoungRHClementPB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of Tumor Pathology. 3rd Series. No. 23. Washington, DC: Armed Forces Institute of Pathology; 1998.
2.
EvansHYatesWAPalmerWECartwrightRLAntemannRW.Clear cell carcinoma of the sigmoid mesocolon: a tumor of the secondary Müllerian system. Am J Obstet Gynecol. 1990;162:161-163.
3.
LeeKRVermaUBelinsonJ.Primary clear cell carcinoma of the peritoneum. Gynecol Oncol. 1991;41:259-262.
4.
TziortziotiVApessouDAntoniouSGiantzoglouAPaissiosP.Clear cell adenocarcinoma of the peritoneum associated with clear cell adenocarcinoma arising in an endometrial polyp. J Obstet Gynaecol. 1999;19:557-558.
5.
IchimuraTIshikoONishimuraSKojimaTShimuraK.Primary peritoneal clear cell carcinoma: excellent results from paclitaxel and carboplatin combination chemotherapy. Oncol Rep. 2001;8:1243-1245.
TeradaTKawaguchiM.Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271-275.
8.
MatsuoKAlonsozanaELEnoMLRosensheinNBImDD.Primary peritoneal clear cell adenocarcinoma arising in previous abdominal scar for endometriosis surgery. Arch Gynecol Obstet. 2009;280:637-641.
9.
TakanoMYoshikawaTKatoM. Primary clear cell carcinoma of the peritoneum: report of two cases and a review of the literature. Eur J Gynaecol Oncol. 2009;30:575-578.
JohnsonSBPrisciandaroJIZhouJHadleySWReynoldsRKJollyS.Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report. J Appl Clin Med Phys. 2014;15:4520.
12.
KurmanRJCarcangiuMLHerringtonCSYoungRH.WHO Classification of Tumors of Female Reproductive Organs. 4th ed.Lyon, France: IARC Press; 2014.
13.
BlossJDLiaoSYBullerRE. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol.1993;50:347-351.
14.
WuntakalRLawrenceA.Are oestrogens and genetic predisposition etiologic factors in the development of clear cell carcinoma of the peritoneum?Med Hypotheses. 2013;80:167-171.
15.
FeeleyKMWellsM.Precursors lesions of ovarian epithelial malignancy. Histopathology. 2001;38:87-95.
16.
LevanonKCrumCDrapkinR.New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol. 2008;26:5284-5293.
17.
KurmanRJShihIM.Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm. Hum Pathol. 2011;42:918-931.
18.
GilbertLBassoOSampalisJ. Assesment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol. 2012;13:285-291.
19.
TangSOnumaKDebP. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol. 2012;3:103-110.
20.
SampsonJA.Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg. 1925;12:1-12.
21.
HittiIFGlasbergSSLubiczS.Clear cell carcinoma arising in extraovarian endometriosis: report of three cases and review of the literature. Gynecol Oncol. 1990;39:314-320.
22.
SternRCDashRBentleyRCSnyderMJHaneyAFRobboySJ.Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol. 2001;20:133-139.
23.
ModesittSCTortolero-LunaGRobinsonJBGershensonDMWolfJK.Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002;100:788-795.
24.
MaedaDShihIeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol. 2013;20:45-52.
25.
JonesSWangTLShihIeM. Frequent mutation of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330:228-231.
26.
GuanBMaoTLPanugantiPK. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol. 2011;35:625-632.
27.
WiegandKCShahSPAl-AghaOM. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532-1543.
28.
JonesSLiMParsonsDW. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat. 2012;33:100-103.
29.
YamamotoSTsudaHTakanoMIwayaKTamaiSMatsubaraO.PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J Pathol. 2011;225:189-194.
30.
YamamotoSTsudaHTakanoMTamaiSMatsubaraO.PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Virchows Arch. 2012;460:77-87.
31.
YamamotoSTsudaHTakanoMTamaiSMatsubaraO.Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol. 2012;25:615-624.
32.
SinghNGilksCBWilkinsonNMcCluggageWG.Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal. Histopathology. 2014;65:149-154.
33.
OrdóñezNG.Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinoma. Am J Surg Pathol. 1998;22:1203-1214.
34.
RamalingamPMalpicaASilvaEGGershensonDMLiuJLDeaversMT.The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28:1499-1505.
